Protective Immunity to SIV Challenge Elicited by Vaccination of Macaques with Multigenic DNA Vaccines Producing Virus-Like Particles-Reference-Cited by-同舟云学术

Protective Immunity to SIV Challenge Elicited by Vaccination of Macaques with Multigenic DNA Vaccines Producing Virus-Like Particles

Published:2004-04 Issue:4 Volume:20 Page:425-434
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Mossman Sally P.¹,Pierce Christopher C.²,Watson Andrew J.²,Robertson Michael N.³,Montefiori David C.⁴,Kuller Larene⁵,Richardson Barbra A.⁶,Bradshaw Jeffrey D.²,Munn Robert J.⁷,Hu Shiu-Lok⁵,Greenberg Philip D.³,Benveniste Raoul E.⁸,Haigwood Nancy L.⁹

Affiliation:

1. Seattle Biomedical Research Institute, Seattle, Washington 98109; and Regional Primate Research Center, University of Washington, Seattle, Washington 98195

2. Seattle Biomedical Research Institute, Seattle, Washington 98109

3. Department of Medicine, University of Washington, Seattle, Washington 98195

4. Duke University Medical Center, Durham, North Carolina 27710

5. Regional Primate Research Center, University of Washington, Seattle, Washington 98195

6. Department of Biostatistics, University of Washington, Seattle, Washington 98195

7. Department of Pathology, University of California, Davis, California 95616

8. Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick, Maryland 21702

9. Seattle Biomedical Research Institute, Seattle, Washington 98109; and Department of Pathobiology, University of Washington, Seattle, Washington 98195

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922204323048177

Reference32 articles.

1. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination

2. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

3. The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

4. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

5. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental co-transmission of Simian Immunodeficiency Virus (SIV) and the macaque homologs of the Kaposi Sarcoma-Associated Herpesvirus (KSHV) and Epstein-Barr Virus (EBV);PLOS ONE;2018-11-16

2. Experimental co-transmission of simian immunodeficiency virus (SIV) and the macaque homologs of the Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV);2018-10-01

3. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIV vaccine efficacy;Vaccine;2015-06

4. DNA Vaccines for the Induction of Immune Responses in Mucosal Tissues;Mucosal Immunology;2015

5. Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially;Vaccine;2012-08